Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by scottpiperon May 15, 2009 9:45am
341 Views
Post# 15995516

L II

L II
Last: 0.105   Change: -0.010   Volume: 4,159,227   Last Trade: 09:44  

  Level ll Quote
  Bid   Ask
  Price
  Total Size
  # of Orders
  Price
  Total Size
  # of Orders
$0.105 801 7 $0.11 541 7
$0.10 1758 25 $0.115 1069 7
$0.095 1106 9 $0.12 1308 21
$0.09 2222 19 $0.125 1293 7
$0.085 3766 19 $0.13 1269 9
$0.08 4334 28 $0.135 1081 7
$0.075 2302 9 $0.14 741 9
$0.07 1578 14 $0.145 324 5
$0.065 270 4 $0.15 2068 16
$0.06 64 1 $0.16 200 1
Bullboard Posts